Replies to post #190617 on Kraig Biocraft Laboratories Inc (KBLB)

[Darryl_T]

" first production run to ship materials are dedicated to fulfill an

outstanding order, ". Sounds good, shipping soon underway! Good share

Col. :) Peace

[arachnodude]

Which, when put in conjunction with our early-2020 PR (1-30-20) and the subsequent SEC Filing of the 10Q for 1Q20, it looks like the breadcrumbs put down were to be the announcements. Equate to 2020 SUCCESS? Moving forward does, IMO.

PR:

“There has been considerable interest in Kraig Labs’ high performance fibers, from multiple internationally recognized brands, so bringing our specialized silkworms online should allow us to deliver our first large batch of fabric and begin to fulfill the fiber request backlog,” said COO Jon Rice. “Having now successfully delivered the silkworms to the factory, watched our team hard at work rearing this first batch, and preparing the factory for the expanding workload, and walked the rows of silk production rack, tray, and mounting boxes, I believe that we are on track to meet our production targets for 2020.”

10Q (for 1Q/2020):

Plan of Operations

During the next twelve months, we expect to take the following steps in connection with the further development of our business and the implementation of our plan of operations:

**We plan to accelerate both our microbiology and selective breeding programs as well as provide more resources for our material testing protocols. We spent approximately $123,050 over the last 12 months on research and development of high strength polymers. In 2019, we directed our research and development efforts on growing our internal capabilities; we plan to continue to dedicate our efforts in 2020 to grow our internal research and development programs.

**We will consider buying an established revenue producing company in a compatible business, in order to broaden our financial base and facilitate the commercialization of our products; as of the date hereof, we have not had any formal discussion or entered into any definitive agreements regarding any such purchase.

**We will also actively consider pursuing collaborative research opportunities with both private and university laboratories in areas of research which overlap the company’s existing research and development. One such potential area for collaborative research which the company is considering is protein expression platforms. If our financing allows, management will give strong consideration to increasing the breadth of our research to include protein expression platform technologies.

**We plan to actively pursue collaborative research and product testing opportunities with companies in the biotechnology, materials, textile and other industries.

**We plan to actively pursue collaborative commercialization, marketing and manufacturing opportunities with companies in the textile and material sectors for the fibers we developed and for any new polymers that we create in the remainder of 2020 and going forward.

**Once safe to restart operation, following the COVID-19 pandemic, we plan resume production operations at our factory in Vietnam and expect to continue to expand our monthly production volumes to address demand for materials.

**We have initiated and plan to accelerate our efforts for large scale US production. This work will include the research and production of a new transgenic tailored specifically domestic production.